| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 444,988 | 429,057 | 347,732 | 388,445 | | Cost of Revenue | 156,093 | 150,939 | 99,714 | 101,465 | | | Gross Profit | 288,895 | 278,118 | 248,018 | 286,980 | | | Operating Expenses | | Research Development | 21,202 | 27,256 | 627,148 | 33,855 | | Selling General and Administrative | 123,575 | 142,323 | 104,911 | 99,278 | | Non Recurring | 1,475 | 48,050 | 8,376 | 1,153 | | Others | 52,862 | 53,349 | 29,515 | 29,695 | | | | Total Operating Expenses | 199,114 | 270,978 | 769,950 | 163,981 | | | | Operating Income or Loss | 89,781 | 7,140 | (521,932) | 122,999 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,094 | (814) | (3,265) | 7,086 | | Earnings Before Interest And Taxes | 94,875 | 6,326 | (525,197) | 130,085 | | Interest Expense | 27,592 | 23,103 | 2,473 | 1,828 | | Income Before Tax | 67,283 | (16,777) | (527,670) | 128,257 | | Income Tax Expense | 29,348 | (6,055) | 20,797 | 43,507 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 37,935 | (10,722) | (548,467) | 84,750 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 37,935 | (10,722) | (548,467) | 84,750 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $37,935 | ($10,722) | ($548,467) | $84,750 |
|
2.03% Nasdaq 
Income Statement
